About Us

Listerdale Life Sciences is a boutique strategic advisory firm founded in 2015 to help life sciences ventures navigate the path from scientific concept to commercial success.

We partner with founders, investors, and industry leaders to solve high-stakes challenges in product development, clinical strategy, regulatory compliance, GMP manufacturing, and market access. Our expertise spans Class II/III medical devices, biotech and pharma, we have expertiese in terminal sterilization, and aseptic production, with deep experience across ISO 13485, FDA, MDR, and NMPA regulatory frameworks.

Since 2015 we have served 25 Clients including universities, venture-backed start-ups, investors and global manufacturers seeking scientific depth, due diligence, regulatory precision, and operational transformation.

About the Founder
Dr. Christopher Wilson is a dual Fellow of the Royal Society of Chemistry and the Royal Society of Medicine, with honorary academic appointments at Radboud University and the University of Hull. He holds a Master’s in Drug Design and a PhD in Soft Condensed Matter.

Chris covers our high profile clients and currently serves as Director of Operational Excellence at a £250M global medical device firm, where he is leading the turnaround of its flagship aseptic manufacturing site, responsible for over > €200M in annual sales and > 500,000 units per year. Chris typically leads has restored site yields from 50% to 96% and eliminated long-standing CAPA backlogs.

Previously, as Founder & CEO of NovioSense, he developed the first tear-based glucose biosensor, led three clinical trials, secured IP across six territories, and exited to a US investor. His work has been published in Science, JACS, and Chemical Science, with patents licensed by DuPont and Dow.